This is, however, unlikely to be the case, because lectin injection experiments in tumor-bearing mice failed to reveal differences in vessel perfusion between PHD3 knock-down tumors and control LM8 tumors (Supplementary Figure S4). This evidence concerns the gene EGLN3 and neoplasm.